EPISODE · May 7, 2026 · 7 MIN
Your First 90 Days on GLP-1: Week-by-Week What to Expect (Don't Quit Before This)
from Telehealth FX Talk - TelehealthFX.com
Take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) — TelehealthFX's 1-on-1 onboarding prepares you for every phase of your first 90 days before you receive your first dose. 24-hour provider review means you are never navigating side effects alone. No hidden fees. Learn more at [https://telehealthfx.com](https://telehealthfx.com) or explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine).📅 The #1 reason people quit GLP-1 medications is unmet expectations. In this episode of TelehealthFX Talk, we walk you through your first 90 days on semaglutide or tirzepatide week-by-week, so you know exactly what to expect, do not panic when it gets hard, and do not make the mistake that costs most people their results.👇 **HERE'S WHAT WE COVER** 👇• **WEEKS 1-2: The Titration Phase** — Starting doses are intentionally LOW (semaglutide 0.25 mg, tirzepatide 2.5 mg). Not the full therapeutic dose — this is calibration. Appetite suppression is mild. Possible nausea, fatigue, constipation — or no side effects at all. Both are normal. What to do: Eat small portions slowly, stop at the first sign of fullness. Avoid high-fat foods. Protein first. Do not weigh yourself obsessively. This is not the results phase yet.• **WEEKS 3-4: The "Food Noise" Shift** — The milestone patients remember forever: "I just forgot to eat." The constant hunger chatter quiets. Cravings for sugar, processed food, and alcohol decrease. Portions naturally shrink without effort. Scale movement typically begins: 4-8 lbs combined in month 1. Energy improves. Nausea lessens. Psychological adjustment: food becomes less emotionally central.• **MONTH 2 (Weeks 5-8): Visible Changes & First Dose Increase** — First dose increase (semaglutide → 0.5 mg; tirzepatide → 5 mg). May temporarily bring back mild nausea for 1-2 weeks. Normal. Not a relapse. Average loss: 1-2 lbs/week (highly individual). Clothes fit differently. People notice. Take photos. Measure your waist. Track energy and sleep.• **MONTH 3 (Weeks 9-12): Habit Lock-In & The Plateau Test** — Full GI adaptation. Lifestyle habits feel automatic. Possible second dose increase. First mini-plateau often appears here. This is NOT failure. This is metabolic adaptation. Stay the course. THIS is where most people who quit, quit — and where most people who succeed, separate themselves. Metabolic markers improve: blood pressure, blood sugar, cholesterol, CRP. These add years to your life.• **THE 3 PREDICTORS OF 90-DAY SUCCESS** — 1. Protein priority: hits protein targets = more fat loss, less muscle loss. 2. Resistance training: start in month 1, dramatically better outcomes at month 6. 3. Provider engagement: check-ins, dose adjustments, and answered questions = far higher retention.⏱️ **TIMESTAMPS** ⏱️0:00 — Introduction: The episode that prevents quitting1:00 — Why unmet expectations are the real enemy1:30 — Weeks 1-2: The titration phase2:30 — Weeks 3-4: The food noise shift3:30 — Month 2: Visible changes and dose increase4:45 — Month 3: Habit lock-in and the plateau test6:00 — The 3 predictors of 90-day success6:45 — TelehealthFX: Prepared before day one7:45 — Visit TelehealthFX🔗 **TAKE THE NEXT STEP** 🔗• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)• Explore berberine options: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)🏢 **ABOUT TELEHEALTHFX** 🏢1-on-1 onboarding sets expectations before you receive your first dose. 24-hour provider review means week-2 nausea does not spiral into medication abandonment. Full titration range available for both semaglutide and tirzepatide. Sermorelin, NAD+, berberine available when the time is right. Transparent pricing. No hidden fees. All 50 states. 2-day UPS shipping.🎯 **WHO THIS EPISODE IS FOR** 🎯Anyone who just started or is about to start a GLP-1 medication. Anyone feeling discouraged in weeks 1-4 because results seem slow. Anyone experiencing nausea and wondering if they should stop. People researching GLP-1 medications who want to understand the full patient journey before committing.Subscribe to TelehealthFX Talk. Next episode: our Season 2 finale — how to choose a telehealth weight loss program (and avoid the scams).⚠️ **IMPORTANT DISCLAIMER** ⚠️This content is for educational purposes only and is not medical advice. Your specific titration schedule and dose adjustments must be determined by your healthcare provider. Individual results vary significantly.#First90Days #GLP1Journey #SemaglutideStart #TirzepatideStart #WeightLossJourney #GLP1 #Wegovy #Mounjaro #Semaglutide #Tirzepatide #FoodNoise #TelehealthFX #TelehealthWeightLoss #ClinicalWeightLoss #NoHiddenFees #WeightLoss #DontQuit #GLP1SideEffects #GLP1Results #MetabolicHealth
What this episode covers
Take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) — TelehealthFX's 1-on-1 onboarding prepares you for every phase of your first 90 days before you receive your first dose. 24-hour provider review means you are never navigating side effects alone. No hidden fees. Learn more at [https://telehealthfx.com](https://telehealthfx.com) or explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine).📅 The #1 reason people quit GLP-1 medications is unmet expectations. In this episode of TelehealthFX Talk, we walk you through your first 90 days on semaglutide or tirzepatide week-by-week, so you know exactly what to expect, do not panic when it gets hard, and do not make the mistake that costs most people their results.👇 **HERE'S WHAT WE COVER** 👇• **WEEKS 1-2: The Titration Phase** — Starting doses are intentionally LOW (semaglutide 0.25 mg, tirzepatide 2.5 mg). Not the full therapeutic dose — this is calibration. Appetite suppression is mild. Possible nausea, fatigue, constipation — or no side effects at all. Both are normal. What to do: Eat small portions slowly, stop at the first sign of fullness. Avoid high-fat foods. Protein first. Do not weigh yourself obsessively. This is not the results phase yet.• **WEEKS 3-4: The "Food Noise" Shift** — The milestone patients remember forever: "I just forgot to eat." The constant hunger chatter quiets. Cravings for sugar, processed food, and alcohol decrease. Portions naturally shrink without effort. Scale movement typically begins: 4-8 lbs combined in month 1. Energy improves. Nausea lessens. Psychological adjustment: food becomes less emotionally central.• **MONTH 2 (Weeks 5-8): Visible Changes & First Dose Increase** — First dose increase (semaglutide → 0.5 mg; tirzepatide → 5 mg). May temporarily bring back mild nausea for 1-2 weeks. Normal. Not a relapse. Average loss: 1-2 lbs/week (highly individual). Clothes fit differently. People notice. Take photos. Measure your waist. Track energy and sleep.• **MONTH 3 (Weeks 9-12): Habit Lock-In & The Plateau Test** — Full GI adaptation. Lifestyle habits feel automatic. Possible second dose increase. First mini-plateau often appears here. This is NOT failure. This is metabolic adaptation. Stay the course. THIS is where most people who quit, quit — and where most people who succeed, separate themselves. Metabolic markers improve: blood pressure, blood sugar, cholesterol, CRP. These add years to your life.• **THE 3 PREDICTORS OF 90-DAY SUCCESS** — 1. Protein priority: hits protein targets = more fat loss, less muscle loss. 2. Resistance training: start in month 1, dramatically better outcomes at month 6. 3. Provider engagement: check-ins, dose adjustments, and answered questions = far higher retention.⏱️ **TIMESTAMPS** ⏱️0:00 — Introduction: The episode that prevents quitting1:00 — Why unmet expectations are the real enemy1:30 — Weeks 1-2: The titration phase2:30 — Weeks 3-4: The food noise shift3:30 — Month 2: Visible changes and dose increase4:45 — Month 3: Habit lock-in and the plateau test6:00 — The 3 predictors of 90-day success6:45 — TelehealthFX: Prepared before day one7:45 — Visit TelehealthFX🔗 **TAKE THE NEXT STEP** 🔗• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)• Explore berberine options: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)🏢 **ABOUT TELEHEALTHFX** 🏢1-on-1 onboarding sets expectations before you receive your first dose. 24-hour provider review means week-2 nausea does not spiral into medication abandonment. Full titration range available for both semaglutide and tirzepatide. Sermorelin, NAD+, berberine available when the time is right. Transparent pricing. No hidden fees. All 50 states. 2-day UPS shipping.🎯 **WHO THIS EPISODE IS FOR** 🎯Anyone who just started or is about to start a GLP-1 medication. Anyone feeling discouraged in weeks 1-4 because results seem slow. Anyone experiencing nausea and wondering if they should stop. People researching GLP-1 medications who want to understand the full patient journey before committing.Subscribe to TelehealthFX Talk. Next episode: our Season 2 finale — how to choose a telehealth weight loss program (and avoid the scams).⚠️ **IMPORTANT DISCLAIMER** ⚠️This content is for educational purposes only and is not medical advice. Your specific titration schedule and dose adjustments must be determined by your healthcare provider. Individual results vary significantly.#First90Days #GLP1Journey #SemaglutideStart #TirzepatideStart #WeightLossJourney #GLP1 #Wegovy #Mounjaro #Semaglutide #Tirzepatide #FoodNoise #TelehealthFX #TelehealthWeightLoss #ClinicalWeightLoss #NoHiddenFees #WeightLoss #DontQuit #GLP1SideEffects #GLP1Results #MetabolicHealth
NOW PLAYING
Your First 90 Days on GLP-1: Week-by-Week What to Expect (Don't Quit Before This)
No transcript for this episode yet
Similar Episodes
Feb 8, 2026 ·4m
Jan 30, 2026 ·6m
Dec 15, 2025 ·2m
Nov 30, 2025 ·5m
Oct 26, 2025 ·14m
Oct 26, 2025 ·61m